Equities

Take Solutions Ltd

Take Solutions Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)19.95
  • Today's Change-0.150 / -0.75%
  • Shares traded407.16k
  • 1 Year change+10.53%
  • Beta1.7031
Data delayed at least 15 minutes, as of Jun 06 2024 11:01 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

TAKE Solutions Limited is an India-based company, which provides domain-intensive services as a full-service clinical research organization (CRO) supporting pharma, biotech, and devices companies across the world. The Company operates through two segments: Life Sciences and Supply Chain Management. It offers full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its services spans from clinical trials to regulatory submissions to post-marketing safety. It provides services in life sciences sector across the spectrum of clinical, regulatory, safety and pharmacovigilance, networks, and consulting to deliver end-to-end solutions and services across processes, technology, and analytics to both domestic and global clients. It also provides information technology (IT) infrastructure and support, engineering, designing, and sourcing services. The Company operates in North America, Europe, Asia, and South America.

  • Revenue in INR (TTM)656.08m
  • Net income in INR-1.20bn
  • Incorporated2000
  • Employees211.00
  • Location
    Take Solutions LtdNo27Tank Bund Road, Nungambakkam, ChennaiCHENNAI 600034IndiaIND
  • Phone+91 4 466110700
  • Fax+91 4 445909009
  • Websitehttps://www.takesolutions.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Bafna Pharmaceuticals Ltd1.52bn73.48m2.13bn588.0028.922.6317.241.403.113.1164.5034.171.104.123.52--5.305.458.328.2329.8834.174.825.971.202.670.2318--32.0628.44-35.19--116.51--
SMS Lifesciences India Ltd3.22bn90.93m2.30bn567.0025.321.3010.830.714730.0730.071,064.80584.840.82032.696.61--1.614.082.696.7330.1629.331.964.460.51231.590.34222.61-3.04-4.13-20.68-12.62-3.090.00
Par Drugs and Chemicals Ltd956.40m145.01m2.76bn105.0019.043.2215.392.8911.7811.7877.7269.591.007.076.23--15.2313.5217.6816.4664.6750.2615.1613.424.46180.960.00---0.113215.6027.9442.0177.72--
Take Solutions Ltd656.08m-1.20bn2.99bn211.00------4.55-8.18-8.184.55-0.60680.419931.101.73---76.50-10.20-195.27-16.6762.7570.47-182.19-18.300.3868-3.931.31---65.30-49.71-155.25---47.18--
Medico Remedies Ltd1.45bn82.91m3.07bn--37.375.8627.492.120.990.9917.316.311.586.103.38--9.036.1516.7012.4024.1625.265.723.991.3412.180.1332--3.198.2114.4939.49-7.58--
Lyka Labs Ltd1.11bn-26.80m3.86bn713.00--5.6737.953.47-4.03-4.0343.6219.100.72155.434.72---1.70-5.48-2.21-8.3059.6661.70-2.36-9.161.090.59560.4621--19.479.4581.16--13.88--
Data as of Jun 06 2024. Currency figures normalised to Take Solutions Ltd's reporting currency: Indian Rupee INR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.